ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to slash leukemia relapse after transplant
Disease control Recruiting nowThis study is testing if adding two drugs, ruxolitinib and decitabine, to the standard pre-transplant treatment can better prevent leukemia from coming back. It will involve 200 high-risk acute myeloid leukemia patients who are in their first remission and receiving a donor stem …
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: PHASE4 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
Researchers test if kidney health changes transplant drug dose for leukemia patients
Disease control Recruiting nowThis study aims to understand how kidney function and race/ethnicity affect how the body processes a drug called treosulfan, which is used to prepare patients for a stem cell transplant. The research involves 36 adults with acute myeloid leukemia or myelodysplastic syndrome who a…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Phase: PHASE1 • Sponsor: medac GmbH • Aim: Disease control
Last updated Apr 01, 2026 22:56 UTC
-
Scientists hunt for early warning signs of dangerous lung damage after transplants
Knowledge-focused Recruiting nowThis study aims to find better ways to detect early lung inflammation and scarring in people who receive stem cell transplants from donors. Researchers will regularly test 40 participants with special low-radiation chest scans, lung fluid collection, and blood tests for two years…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT)
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:39 UTC